>

Zoetis Stock Profile

<div class='circular--portrait' style='background:#2A0CD0;color: white;font-size:3em;padding-top: 40px;;'>ZTS</div>

Performance

10 / 100

Odds of Distress

8
Equity ratings for Zoetis are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting November 30, 2019 and ending today February 28, 2020. Click here to learn more.

Zoetis Profile

Next fiscal quarter end is expected on March 31, 2020. Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. The company was founded in 1952 and is headquartered in Parsippany, New Jersey. Zoetis operates under Drug ManufacturersSpecialty Generic classification in USA and is traded on BATS Exchange. It employs 10600 people. more on Zoetis
Legal NameZoetis
CEOKristin PeckView All
Thematic Classification
Currently Active Investing Idea
  Obamacare Repeal
View All
Average Analyst Recommendation
Current trade recommendation based on an ongoing consensus estimate among financial analysis covering Zoetis
Piotroski F Score
Academic score to determine the current strength of Zoetis financial position
Macroaxis Advice
Macroaxis buy hold or sell recommendation provided in the context of your current investment horizon and risk tolerance.
Horizon: 30 days (very short)Advice
Financial Strength
Zoetis ability to generate sufficient cash flow to pay bills, repay debt, and make consistent year-to-year profit
Total Debt
Debt Current
Debt Non Current
Long Term Debt to Equity
Debt to Equity Ratio
Return on Investment
Return on Average Assets
Return on Average Equity
Return on Invested Capital
Return on Sales
Earnings per Basic Share
Earnings per Diluted Share
Price to Earnings Ratio
Earnings before Tax
Average Bond Rating: BBB-Tolerable
Profitability
Few selected profitability drivers of Zoetis representing accounts that assess its ability to generate profits relative to its revenue, operating costs, and shareholders' equity
Consolidated Income
Net Income
Net Income Common Stock
Operating Income
Income Tax Expense
Net Income Per Employee
Operating Margin
EBITDA Margin
Gross Margin
Profit Margin
Zoetis (ZTS) is traded on BATS Exchange in USA and employs 10,600 people. The company currently falls under 'Large-Cap' category with total capitalization of 63.2 B. Zoetis runs under Healthcare sector within Drug Manufacturers?Specialty & Generic industry. The entity has 476.3 M outstanding shares of which 4.85 M shares are at this time shorted by investors with about 2.53 days to cover shorted positions. has about 1.84 B in cash with 1.08 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.86.
Check Zoetis Probability Of Bankruptcy

Ownership Allocation (%)

Zoetis Stock Price Odds Analysis

Odds Down 134.82HorizonTargetOdds Up 134.82
57.54%30 days 134.82 42.25%
Based on normal probability distribution, the odds of Zoetis to move above current price in 30 days from now is about 42.25 (This Zoetis probability density function shows the probability of Zoetis Stock to fall within a particular range of prices over 30 days) .

Zoetis Stock Top Holders

Zoetis Income Statement Over Time

Direct Expenses    Earning Before Interest and Taxes EBIT    Net Income    

Zoetis Stock Against Markets

Did you try this?

Run Performance Analysis Now

   

Performance Analysis

Check effects of mean-variance optimization against your current asset allocation
All  Next Launch Module

Zoetis Upcoming and Recent Events

Zoetis Company Earnings Announcements Dates

Upcoming Quarterly Earning ReportMay 7, 2020
Next Earnings ReportAugust 4, 2020
Next Fiscal Quarter EndMarch 31, 2020
Next Fiscal Year EndFebruary 11, 2021
Last Quarter Report DateDecember 31, 2019
Last Earning Anouncement DateMarch 31, 2019

Zoetis Distributions to stockholders

Zoetis Corporate Directors

William Steere Independent Director
Linda Rhodes Independent Director
Frank DAmelio Independent Director
Check out Your Current Watchlist. Please also try Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Company logos by clearbit